Target intelligence / Profile preview

ATP-binding cassette sub-family G member 2 (ABCG2) (ABCG2)

Target
ABCG2
Molecular classification
Transporter, ATP-binding cassette transporter, Primary active transporter
01

Overview

ATP-binding cassette sub-family G member 2 (ABCG2) is a critical plasma membrane efflux transporter that belongs to the ATP-binding cassette (ABC) superfamily. Unlike many other ABC transporters, ABCG2 is a "half-transporter" that must form homodimers or higher-order oligomers to become functionally active. It is highly expressed in the apical membranes of the epithelium in the small intestine, liver canalicular membrane, and kidney proximal tubules, as well as in the endothelial cells of the blood-brain barrier and the syncytiotrophoblasts of the placenta. Its primary biological role is the protection of the body against xenobiotic toxins by limiting their absorption and promoting their excretion.

In the context of oncology, ABCG2 is frequently overexpressed in various cancer types, where it contributes significantly to multidrug resistance (MDR) by actively pumping out chemotherapeutic agents such as mitoxantrone and topotecan. Furthermore, ABCG2 is a high-capacity urate exporter; genetic variants like the Q141K polymorphism significantly reduce its transport activity, leading to hyperuricemia and an increased risk of gout. Due to its broad substrate specificity, ABCG2 is a major determinant of the pharmacokinetics and toxicity profiles of numerous drugs, making it a focal point for regulatory drug-drug interaction studies.

Other names
Breast cancer resistance proteinBCRPMitoxantrone resistance-associated proteinMXRPlacenta-specific ABC transporterABCPCD338Urate exporter
02

Mechanism of action

ATP-dependent efflux transporter that pumps substrates out of the cytoplasm or cell membrane to the extracellular space, thereby reducing intracellular drug accumulation and mediating resistance.

03

Biological functions

Xenobiotic transportUric acid homeostasisDrug effluxStem cell protectionBlood-brain barrier maintenanceBlood-placenta barrier maintenance
04

Disease associations

CancerGoutHyperuricemiaMultidrug resistanceNeonatal hyperbilirubinemia
05

Safety considerations

Drug-drug interactionsIncreased toxicity due to genetic polymorphismsStatin-induced myopathyAltered pharmacokinetics of narrow therapeutic index drugs
06

Interacting drugs

11 more in the full profile.

07

Biomarkers

ABCG2 protein expressionABCG2 mRNA levelsrs2231142 (Q141K) polymorphismrs2231137 polymorphism

Beyond the preview

Go deeper on ATP-binding cassette sub-family G member 2 (ABCG2) (ABCG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family G member 2 (ABCG2) (ABCG2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call